Aplastic anemia surgery: Difference between revisions
No edit summary |
No edit summary |
||
| Line 6: | Line 6: | ||
==Surgery== | ==Surgery== | ||
===Surgery and Device Based Therapy=== | ===Surgery and Device Based Therapy=== | ||
Treating aplastic anemia involves suppression of the [[immune system]] | Treating aplastic anemia involves suppression of the [[immune system]], a [[bone marrow transplant]], a potential cure but a risky procedure. The transplanted [[bone marrow]] replaces the failing [[bone marrow]] cells with new ones from a matching donor. The [[pluripotency|pluripotent]] [[stem cell]]s in the [[bone marrow]] reconstitute all three [[blood cell]] lines, giving the patient a new immune system, red [[blood cell]]s, and [[platelet]]s. However, besides the risk of [[graft]] failure, there is also a risk that the newly created [[white blood cell]]s may attack the rest of the [[body]] ("[[graft-versus-host disease]]"). | ||
==References== | ==References== | ||
{{reflist|2}} | {{reflist|2}} | ||
Revision as of 17:33, 19 August 2015
|
Aplastic anemia Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Aplastic anemia surgery On the Web |
|
American Roentgen Ray Society Images of Aplastic anemia surgery |
|
Risk calculators and risk factors for Aplastic anemia surgery |
Editor-In-Chief: Aric Hall, M.D., Beth Israel Deaconess Medical Center, Boston, MA [1]
Overview
Surgery
Surgery and Device Based Therapy
Treating aplastic anemia involves suppression of the immune system, a bone marrow transplant, a potential cure but a risky procedure. The transplanted bone marrow replaces the failing bone marrow cells with new ones from a matching donor. The pluripotent stem cells in the bone marrow reconstitute all three blood cell lines, giving the patient a new immune system, red blood cells, and platelets. However, besides the risk of graft failure, there is also a risk that the newly created white blood cells may attack the rest of the body ("graft-versus-host disease").